Vitamin C Works – 12 Trial Review Concludes

12 trials image

Can vitamin C actually treat or prevent Covid infection from becoming serious? A review of twelve studies, including five ‘gold standard’ randomised controlled trials, shows that this simple vitamin can, and is, saving lives when given in the right dose.

The review, including the five randomised controlled trials, is published in the journal Life (see, and was carried out and funded by VitaminC4Covid.

Watch this short film interview with myself, for the full story about the latest evidence from 12 studies of vitamin C for covid.

The review was announced in The Sunday Telegraph’s online article ‘Vitamin C can ‘help to prevent severe Covid and speed up recovery’, and in The Daily Telegraph today, breaking the major media silence about vitamin C’s evidence against covid.

Daily Telegraph piece

VitaminC4Covid is a team of vitamin C experts including myself, Dr Marcela Vizcaychipi from the Faculty of Medicine at London’s Imperial College, and Associate Professor Anitra Carr who heads the Nutrition in Medicine group at the University of Otago where they have been monitoring all Covid-related studies on vitamin C.

The studies show that Covid patients have depleted vitamin C levels, often to the level found in scurvy, and need substantial doses to recover and survive.

Dr Vizcaychipi, who heads research in intensive care medicine at the Chelsea & Westminster Hospital has been giving Covid patients in their Intensive Care Units up to 6g of vitamin C intravenously. The dosage is dependent on the severity of disease and the amount needed to correct deficiency, as indicated by vitamin C urine sticks.
“Vitamin C is certainly one of multiple factors that contributes to better outcomes and speed of recovery. It should be standard practice. We have not had any safety issues at all.” says Dr Vizcaychipi, who heads research in intensive care medicine at the Chelsea & Westminster Hospital.

The review of 12 clinical trials shows that ‘intravenous vitamin C may improve oxygenation parameters, reduce inflammatory markers, decrease days in hospital and reduce mortality, particularly in the more severely ill patients.’

Vitamin C is both an antioxidant and an anti-viral, and is also anti-inflammatory – so an impressive three-in-one defender. Not one adverse event has been reported in any published vitamin C clinical trials in COVID-19 patients. Also, vitamin C tablets upon infection may also keep people out of hospital. According to Carr “Oral doses of 8 grams per day have been shown to increase the rate of recovery from symptomatic infection by 70%.”

Write to your MP using the link here and get this vital information on the government agenda.